What does APOTHEEK PHARMAVIE do?

APOTHEEK PHARMAVIE is a logistics company in Assenede. Private Limited, started on 1 October 1987, 1 establishment.

What is the address of APOTHEEK PHARMAVIE?

The registered office of APOTHEEK PHARMAVIE is located at Hoogstraat 5, 9960 Assenede.

Is APOTHEEK PHARMAVIE still active?

Yes. According to the CBE (31 October 2026) APOTHEEK PHARMAVIE is active, legal situation “Normale toestand”, started on 1 October 1987.

Is APOTHEEK PHARMAVIE registered on Peppol?

Yes, APOTHEEK PHARMAVIE is registered on the Peppol network with ID 0208:0432179441.

What is the enterprise number of APOTHEEK PHARMAVIE?

The enterprise number of APOTHEEK PHARMAVIE is BE0432179441.

When was APOTHEEK PHARMAVIE founded?

APOTHEEK PHARMAVIE was founded on 1 October 1987.

Who are the directors of APOTHEEK PHARMAVIE?

According to the 2025 annual accounts, the directors of APOTHEEK PHARMAVIE are: Group De Surgeloose BV.

Is APOTHEEK PHARMAVIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PHARMAVIE make in 2025?

APOTHEEK PHARMAVIE recorded a loss after taxes of € 28,835 in financial year 2025.

What is the revenue of APOTHEEK PHARMAVIE?

As a small company, APOTHEEK PHARMAVIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 274,618.

How much does an employee at APOTHEEK PHARMAVIE earn?

The average wage cost per full-time employee at APOTHEEK PHARMAVIE was € 66,000 in 2025: staff costs of € 211,178 for 3.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK PHARMAVIE have?

According to the 2025 annual accounts, APOTHEEK PHARMAVIE has 3.2 full-time equivalents (FTE).

Does APOTHEEK PHARMAVIE have a website?

Yes, APOTHEEK PHARMAVIE has a website at pharmavie.be.

APOTHEEK PHARMAVIE (Private Limited) - Assenede

Dossier APOTHEEK PHARMAVIE, printed on 31 October 2026 from databakkes.be/en/0432179441/apotheek-pharmavie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK PHARMAVIE from Assenede, company number BE0432179441, closed financial year 2025 with a result of € -28,835 after tax. For that financial year APOTHEEK PHARMAVIE recorded a gross margin of € 274,618 and equity of € 46,977. Compared with financial year 2024, the result moved from € 57,339 to € -28,835. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Healthy

€ 46,977

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -28,835

▼ still € 57,339 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 208,019

▲ 131% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -9,023.

People and assets in 2025

Full-time equivalents

3.2

▲ 1.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 211,178

▲ 72% vs 2024

€ 66,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 608,347

▲ € 555,124 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.7 million

▲ € 1.4 million vs 2024

€ 395,811 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 439,862

▲ 69% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 22,802

▲ 201% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 296,067 Gross margin 2022: € 296,067 First fiscal year in the series	€ 256,987 Gross margin 2023: € 256,987 ▼ 13% vs 2022 (€ 296,067) Unfavourable step	€ 257,346 Gross margin 2024: € 257,346 Unchanged (€ 256,987) Favourable step	€ 274,618 Gross margin 2025: € 274,618 ▲ 7% vs 2024 (€ 257,346) Favourable step	▲ 7%
Profit after taxes	€ 107,229 Profit after taxes 2022: € 107,229 First fiscal year in the series	€ 68,469 Profit after taxes 2023: € 68,469 ▼ 36% vs 2022 (€ 107,229) Unfavourable step	€ 57,339 Profit after taxes 2024: € 57,339 ▼ 16% vs 2023 (€ 68,469) Unfavourable step	€ -28,835 Profit after taxes 2025: € -28,835 ▼ € 86,174 vs 2024 (€ 57,339) Unfavourable step	▼ € 86,174
Equity	€ 70,004 Equity 2022: € 70,004 First fiscal year in the series	€ 138,473 Equity 2023: € 138,473 ▲ 98% vs 2022 (€ 70,004) Favourable step	€ 75,812 Equity 2024: € 75,812 ▼ 45% vs 2023 (€ 138,473) Unfavourable step	€ 46,977 Equity 2025: € 46,977 ▼ 38% vs 2024 (€ 75,812) Unfavourable step	▼ 38%
Total debts	€ 696,267 Total debts 2022: € 696,267 First fiscal year in the series	€ 542,446 Total debts 2023: € 542,446 ▼ 22% vs 2022 (€ 696,267) Favourable step	€ 683,420 Total debts 2024: € 683,420 ▲ 26% vs 2023 (€ 542,446) Unfavourable step	€ 2,133,490 Total debts 2025: € 2,133,490 ▲ 212% vs 2024 (€ 683,420) Unfavourable step	▲ 212%
Cash	€ 50,691 Cash 2022: € 50,691 First fiscal year in the series	€ 25,394 Cash 2023: € 25,394 ▼ 50% vs 2022 (€ 50,691) Unfavourable step	€ 89,935 Cash 2024: € 89,935 ▲ 254% vs 2023 (€ 25,394) Favourable step	€ 208,019 Cash 2025: € 208,019 ▲ 131% vs 2024 (€ 89,935) Favourable step	▲ 131%
Land & buildings	€ 26,557 Land & buildings 2022: € 26,557 First fiscal year in the series	€ 20,088 Land & buildings 2023: € 20,088 ▼ 24% vs 2022 (€ 26,557) Unchanged	€ 9,485 Land & buildings 2024: € 9,485 ▼ 53% vs 2023 (€ 20,088) Unchanged	€ 5,563 Land & buildings 2025: € 5,563 ▼ 41% vs 2024 (€ 9,485) Unchanged	▼ 41%
Retained profit	€ 14,004 Retained profit 2022: € 14,004 First fiscal year in the series	€ 82,473 Retained profit 2023: € 82,473 ▲ € 68,469 vs 2022 (€ 14,004) Favourable step	€ 19,812 Retained profit 2024: € 19,812 ▼ 76% vs 2023 (€ 82,473) Unfavourable step	€ -9,023 Retained profit 2025: € -9,023 ▼ € 28,835 vs 2024 (€ 19,812) Unfavourable step	▼ € 28,835
Dividend	€ 125,000 Dividend 2022: € 125,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 125,000) Unchanged	€ 120,000 Dividend 2024: € 120,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 120,000) Unchanged	▼ 100%
Bank debt	€ 317,035 Bank debt 2022: € 317,035 First fiscal year in the series	€ 306,537 Bank debt 2023: € 306,537 ▼ 3% vs 2022 (€ 317,035) Favourable step	€ 295,909 Bank debt 2024: € 295,909 ▼ 3% vs 2023 (€ 306,537) Favourable step	€ 1,670,826 Bank debt 2025: € 1,670,826 ▲ € 1.4 million vs 2024 (€ 295,909) Unfavourable step	▲ € 1.4 million
Balance sheet total	€ 766,271 Balance sheet total 2022: € 766,271 First fiscal year in the series	€ 680,919 Balance sheet total 2023: € 680,919 ▼ 11% vs 2022 (€ 766,271) Unchanged	€ 759,232 Balance sheet total 2024: € 759,232 ▲ 12% vs 2023 (€ 680,919) Unchanged	€ 2,180,467 Balance sheet total 2025: € 2,180,467 ▲ 187% vs 2024 (€ 759,232) Unchanged	▲ 187%
Employees (FTE)	2.1 Employees (FTE) 2022: 2.1 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 ▼ 0.3 vs 2022 (2.1) Unchanged	2 Employees (FTE) 2024: 2 ▲ 0.2 vs 2023 (1.8) Unchanged	3.2 Employees (FTE) 2025: 3.2 ▲ 1.2 vs 2024 (2) Unchanged	▲ 1.2

Key figures of APOTHEEK PHARMAVIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PHARMAVIE?

What happened at APOTHEEK PHARMAVIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: loss of € 28,835 (▼ € 86,174 vs 2024). Source: NBB ↗
Nov 19, 1987 New establishment in Assenede. KBO
Oct 1, 1987 Start of the company according to the CBE. KBO

In short

From € 107,229 profit in 2022 to € 28,835 loss in 2025.

Paid € 84,593 in corporate taxes since 2022.

Best year ever: 2022, with € 107,229 profit.

On average € 85,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

GROUP DE SURGELOOSE 100%

The stake of GROUP DE SURGELOOSE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PHARMAVIE

Behind APOTHEEK PHARMAVIE is Group De Surgeloose BV. The shares are held by GROUP DE SURGELOOSE (100%).

Directors

According to the 2025 annual accounts

Group De Surgeloose BV

Director · represented by Frank De Surgeloose

Also active at: Ipharma

Shareholders

GROUP DE SURGELOOSE

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Hoogstraat 5

9960 Assenede

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Vereniging van mede-eigenaars Residentie VALENTINO, Hoogstraat 5, te 9960 Assenede.

GROUP DE SURGELOOSE same network

€ 163,542 gross margin · 2025

RADIOLOGIE DOKTER FRANS

€ 607,290 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmavie.be

Technologies

AWS S3BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsOwl CarouselPHPSwiperWP RocketWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

one.com Mail

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0432.179.441

VAT number

BE 0432.179.441

Registered office

Hoogstraat 5, 9960 Assenede

Names & denominations

APOTHEEK PHARMAVIE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 October 1987

Peppol

Active · Active since 23 Dec 2025

Contact

pharmavie.be

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PHARMAVIE

Warning lights

Financials

What happened to APOTHEEK PHARMAVIE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions